5721 - 5730 of 5832 Results
Title
Year
-
OPENTitle: α-Synuclein is part of a diverse and highly conserved interaction network that includes PARK9 and manganese toxicityJournal Name: Nature GeneticsPublisher: Springer Science and Business Media LLCVol: 41Issue #: 3Start Page: 308End Page: 315Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/ng.300Best OA location URL: https://europepmc.org/articles/pmc2683786?pdf=renderCitation Count: 527
-
OPENTitle: Evidence that DmMANF is an invertebrate neurotrophic factor supporting dopaminergic neuronsJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 106Issue #: 7Start Page: 2429End Page: 2434Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1073/pnas.0810996106Best OA location URL: https://europepmc.org/articles/pmc2650173?pdf=renderCitation Count: 136
-
OPENTitle: FGF20 and Parkinson's disease: No evidence of association or pathogenicity via α‐synuclein expressionJournal Name: Movement DisordersPublisher: WileyVol: 24Issue #: 3Start Page: 455End Page: 459Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.22442Best OA location URL: https://europepmc.org/articles/pmc2875476?pdf=renderCitation Count: 44
-
OPENTitle: Funding of Parkinson research from industry and US federal and foundation sourcesJournal Name: Movement DisordersPublisher: WileyVol: 24Issue #: 5Start Page: 731End Page: 737Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.22446Best OA location URL: http://ecommons.library.cornell.edu/bitstream/1813/15097/2/Nicholson 09 pub 02.pdfCitation Count: 6
-
OPENTitle: Future of cell and gene therapies for Parkinson's diseaseJournal Name: Annals of NeurologyPublisher: WileyVol: 64Issue #: S2Start Page: S122End Page: S138Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ana.21473Best OA location URL: https://europepmc.org/articles/pmc3982797?pdf=renderCitation Count: 53
-
OPENTitle: Alzheimer Research Forum Live Discussion: Mice on Trial? Issues in the Design of Drug StudiesJournal Name: Journal of Alzheimer's DiseasePublisher: SAGE PublicationsVol: 16Issue #: 1Start Page: 197End Page: 205Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jad-2009-0961Best OA location URL: https://content.iospress.com:443/download/journal-of-alzheimers-disease/jad00961?id=journal-of-alzheimers-disease%2Fjad00961Citation Count: 1
-
OPENTitle: Expression of inflammatory genes induced by beta-amyloid peptides in human brain endothelial cells and in Alzheimer's brain is mediated by the JNK-AP1 signaling pathwayJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 34Issue #: 1Start Page: 95End Page: 106Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2008.12.007Best OA location URL: https://europepmc.org/articles/pmc2720310?pdf=renderCitation Count: 216
-
OPENTitle: Differentiation of Neural Precursors and Dopaminergic Neurons from Human Embryonic Stem CellsJournal Name: Methods in Molecular BiologyPublisher: Humana PressVol:Issue #:Start Page: 355End Page: 366Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/978-1-60761-369-5_19Best OA location URL: https://europepmc.org/articles/pmc2948208?pdf=renderCitation Count: 97
-
OPENTitle: Linkage of cDNA expression profiles of mesencephalic dopaminergic neurons to a genome-wide in situ hybridization databaseJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 4Issue #: 1Start Page: 6End Page: 6Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/1750-1326-4-6Best OA location URL: https://molecularneurodegeneration.biomedcentral.com/counter/pdf/10.1186/1750-1326-4-6Citation Count: 10
-
OPENTitle: Positive allosteric modulators of the metabotropic glutamate receptor subtype 4 (mGluR4). Part II: Challenges in hit-to-leadJournal Name: Bioorganic & Medicinal Chemistry LettersPublisher: Elsevier BVVol: 19Issue #: 3Start Page: 962End Page: 966Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.bmcl.2008.11.104Best OA location URL: https://europepmc.org/articles/pmc3787871?pdf=renderCitation Count: 55